SUNITINIB-50 belongs to the class of medications called ‘antineoplastic agents’ used in treating gastrointestinal stromal tumors (cancer of the stomach, bowel, or esophagus) in which patients don’t respond to imatinib (another anticancer agent). It is also used to treat renal carcinoma (kidney cancer) that has spread to other parts of the body and advanced pancreatic neuroendocrine tumors (cancer that has affected hormone-producing cells in the pancreas).
SUNITINIB-50 contains sunitinib. It acts by slowing down the growth of cancer cells by two processes. It interferes with the action of a protein that promotes cell division and thereby decreases cancer cell production. It can inhibit a process called angiogenesis, the development of blood supply to the cancer cells. This effect inhibits the nutrient supply to the cancer cells, thereby causing cancer cell death eventually.
You should take this medicine exactly as prescribed by the doctor. The common side-effects of SUNITINIB-50 are difficulty breathing, increase in blood pressure, extreme tiredness, swelling caused by fluid under the skin and around the eye, pain or irritation in the mouth, mouth sores, dry mouth, taste disturbances, upset stomach, nausea, vomiting, diarrhea, constipation, abdominal pain, loss of appetite, decreased activity of thyroid gland (hypothyroidism), dizziness, headache, nose bleeding, back pain, joint pain, pain in arms and legs, yellowish discoloration of the skin, rash on the palms of the hands and soles of the feet, dryness of the skin, cough, fever, and difficulty to sleep. Inform your doctor immediately if any of these side-effects persist or get worse.
It is not recommended to take SUNITINIB-50 if you are allergic to any contents of it. SUNITINIB-50 should be used with caution in patients with high blood pressure, heart problems, diabetes, liver or kidney problems, skin disorders, pancreas or gallbladder problems, history of blood clots, aneurysm (weakening of blood vessel wall), problems with the thyroid gland, pancreas, and gallbladder, liver or kidney problems, and thrombotic microangiopathy (damage to the smallest blood vessels). It is not recommended for use in children and adolescents under 18 years of age. It should be used with caution in pregnant and breastfeeding women. Do not consume alcohol as it may increase the risk of side-effects. SUNITINIB-50 may cause dizziness, so do not drive or operate heavy machinery if you are not fully alert.
Uses of SUNITINIB-50
Gastrointestinal stromal cancer, kidney cancer, and pancreatic neuroendocrine tumors
Medicinal Benefits
SUNITINIB-50 is a targeted therapy used to treat advanced kidney cancer. It is also used in patients with kidney cancer to prevent recurrence after having kidney surgery. It is used to treat gastrointestinal stromal cancer that cannot be treated with imatinib, another anti-cancer medicine. It is used to manage pancreatic neuroendocrine tumors (cancer of hormone-producing cells of the pancreas) that cannot be treated with surgery. SUNITINIB-50 can help to manage the above conditions if taken regularly as prescribed by the doctor.
Directions for Use
SUNITINIB-50 is available in the form of capsules. You can take this medicine with or without food. The capsules should be swallowed as a whole with a glass of water. Do not chew, crush, or break the capsule. The dose and duration are given by the doctor based on your health condition.
Storage
Store in a cool and dry place away from sunlight
No customer reviews for the moment.
It is a drug used for certain breast, lung and other cancers. Gefitinib is the first selective inhibitor of epidermal growth factor receptor’s (EGFR) tyrosine kinase domain. Thus Gefitinib is an EGFR inhibitor. The target protein (EGFR) is a family of receptors which includes Her 1(erb-B1), Her 2(erb-B2), and Her 3(erb-B3). EGFR is over expressed in the...
IMACY-100mgTyrosine kinase inhibitors (TKIs) have been approved for cancer treatment and numerous are under investigation. These drugs are rationally designed to target specific tyrosine kinases that are mutated and/or over-expressed in cancer tissues. Ninety-five percent of all chronic myelogenous leukemia (CML) was suggested to be the result of the...
IMACY-400mg n Tyrosine kinase inhibitors (TKIs) have been approved for cancer treatment and numerous are under investigation. These drugs are rationally designed to target specific tyrosine kinases that are mutated and/or over-expressed in cancer tissues.Ninety-five percent of all chronic myelogenous leukemia (CML) was suggested to be the result of the...
BORTENAT2MG INGREDIENT-Bortenat injection contain BortezomibINTRODUCTION-Bortenat 2mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma.
DASATINIB-20mgDasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
DASATINIB-50mgDasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
DASATINIB-70mg Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL). Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
CYNIVE-3(Ivermectin USP 3 mg) This medication is used to treat certain parasitic roundworm infections. In people with weakened defense (immune) systems, curing roundworm infections can reduce the risk of developing a severe or life-threatening infection. Ivermectin belongs to a class of drugs known as anthelmintic. It works by paralyzing and killing...
CYNIVE-6(Ivermectin USP 6 mg) This medication is used to treat certain parasitic roundworm infections. In people with weakened defense (immune) systems, curing roundworm infections can reduce the risk of developing a severe or life-threatening infection. Ivermectin belongs to a class of drugs known as anthelmintic. It works by paralyzing and killing...
CYNIVE-12(Ivermectin USP 12 mg) This medication is used to treat certain parasitic roundworm infections. In people with weakened defense (immune) systems, curing roundworm infections can reduce the risk of developing a severe or life-threatening infection. Ivermectin belongs to a class of drugs known as anthelmintic. It works by paralyzing and killing...
FAVIPIRAVIR - 200 mgFavipiravir was discovered for antiviral activity against the influenza virus by chemical modification of a pyrazine analog in a pyrazine carboxamide derivative (6-fluoro-3-hydroxy-2-pyrazinecarboxamide). It was approved for medical use in 2014, for the treatment of the new or re-emerging pandemic influenza virus infections....
FAVIPIRAVIR - 400 mgFavipiravir was discovered for antiviral activity against the influenza virus by chemical modification of a pyrazine analog in a pyrazine carboxamide derivative (6-fluoro-3-hydroxy-2-pyrazinecarboxamide). It was approved for medical use in 2014, for the treatment of the new or re-emerging pandemic influenza virus infections....
FAVIPIRAVIR - 800 mgFavipiravir was discovered for antiviral activity against the influenza virus by chemical modification of a pyrazine analog in a pyrazine carboxamide derivative (6-fluoro-3-hydroxy-2-pyrazinecarboxamide). It was approved for medical use in 2014, for the treatment of the new or re-emerging pandemic influenza virus infections....
MOLNUPIRAVIR - 200 mgMolnupiravir, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2.. Molnupiravir is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral action by introducing copying errors during viral RNA...
Pharmacology of Drug: Tenofovir Alafenamide (25mg)
Pirfenidone, a prescription medication, treats idiopathic pulmonary fibrosis by reducing lung scarring and swelling, improving breathing. Take it with food at the same time daily. Common side effects include insomnia, headache, dizziness, nausea, and photosensitivity. Inform your doctor about liver or kidney disease and other medications you’re taking. If...